Brainstorm Cell Therapeutics Inc.

OTC: BCLI · Healthcare · Biotechnology

PublicHQ New York City, NY · New YorkCIK 0001137883Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH 5DQ —GM —SS 58

v0.1 · 35/100 weight · pillars only

↑ listing tenure, market scale · ↓ Piotroski F, Altman-Z

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$10.3M

Employees

Market cap

$15.9M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$10.3M-$10.3M2025

Operating income-$10.0M-$10.0M2025

Total assets$1.0M$1.0M2025

Liabilities$11.0M$11.0M2025

Equity-$10.0M-$10.0M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Brainstorm Cell Therapeutics Inc. earned -$10.3M in FY2025 net income.

Peers · Healthcare

Marker Therapeutics, Inc.36D Exlites Holdings International, Inc.54D Zenith Capital Corp.——Selectis Health, Inc.61C

Neighbors

New York →

JPMorgan Chase & Co.$182.4B72B Morgan Stanley$34.3B60C The Goldman Sachs Group, Inc.——Philip Morris International Inc.$40.6B86A American Express Company$41.3B78B+Citigroup Inc.$85.2B56C

Key facts

CEOChaim Lebovits

SectorHealthcare

IndustryBiotechnology

HeadquartersNew York City, NY

ExchangeOTC: BCLI

Employees27

IPO date2003-10-07

Latest filings

8-K2026-05-28 8-K2026-05-15 10-Q2026-05-15 10-K2026-03-31 8-K2026-03-31 8-K2026-02-27 8-K2026-02-13 8-K2026-01-09

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.